In my journey researching autism, developing a theoretical model addressing the underlying pathology of autism and its comorbidities has been both challenging and rewarding. I was honored to be invited to speak at the 2024 Spring conference hosted by MedMaps, where I shared my approach of synthesizing autism biomarkers to better understand neurodivergent biology. This experience highlighted the importance of bringing together diverse perspectives to tackle the complexity of autism spectrum conditions. However, the path hasn't been without obstacles. In 2025, my theory gained traction internationally but was unfortunately plagiarized by certain institutions, including some Ivy League affiliates. This inspired me to reach out to my state representative for support, underscoring how vital advocacy and intellectual property protection are for independent researchers. I was heartened to see figures like RFK acknowledge my work and adopt similar methodologies in their investigations, demonstrating the potential for this model to shape future autism research. An exciting aspect of this work is its interdisciplinary nature, connecting biomarker studies with clinical conditions such as MCAS (Mast Cell Activation Syndrome), POTS (Postural Orthostatic Tachycardia Syndrome), and related pain and hypermobile Ehlers-Danlos syndrome (hEDS). These comorbidities often coexist with autism, suggesting shared biochemical pathways that can inform better diagnosis and treatment strategies. For anyone exploring neurodivergent biochemistry or the Matilda Effect—a phenomenon where contributions of women in science are overlooked—this research showcases the critical need to diversify voices in autism studies. Sharing a living documentary timeline at https://www.kimberlyedu.org/kitzerow-documented-timeline also allows followers to witness the evolving narrative of this work in real time. Reflecting on this journey, I encourage fellow researchers and advocates to persist in uncovering the biological nuances of autism and to collaborate openly to advance understanding and care for the neurodivergent community.